Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | 0.00% | +6.51% | +2.85% |
Business Summary
Number of employees: 20
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 0 | 100.0 % | 5 | 100.0 % | +2,093.30% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 5 | 100.0 % | +2,093.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01/02/01 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 06/20/06 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 27/23/27 |
Norman LaFrance
CTO | Chief Tech/Sci/R&D Officer | 76 | 08/21/08 |
Russ Havranek
PRN | Corporate Officer/Principal | - | 01/14/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01/02/01 |
Richard Hawkins
CHM | Chairman | 75 | 01/07/01 |
Robert Lenk
BRD | Director/Board Member | 75 | 01/20/01 |
J. Clowes
BRD | Director/Board Member | 70 | 01/20/01 |
Greg Petersen
BRD | Director/Board Member | 61 | 14/20/14 |
Director/Board Member | 64 | 01/20/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,354,641 | 4,214,074 ( 96.77 %) | 78,559 ( 1.804 %) | 96.77 % |
Company contact information
Plus Therapeutics, Inc.
4200 Marathon Boulevard Suite 200
78756, Austin
+737 255 7194
http://www.plustherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.85% | 7.7M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- PSTV Stock
- Company Plus Therapeutics, Inc.